Tuesday, May 18 from 7AM-10:30AM EST | Friday, May 21 from 8AM-11:30AM EST | Tuesday, May 25 from 8AM-11:30AM EST
The global response to COVID-19 has pushed the boundaries on what is possible for rapid pandemic response in several areas, including advancing vaccine research and development, bolstering vaccine distribution and supply chains, reinforcing non-vaccine public health interventions and countermeasures, and encouraging global coordination, partnerships and financing. Furthermore, the global COVID-19 response has provided new data around the efficacy and best practices surrounding pandemic planning and response.
This global public workshop will convene international experts, thought-leaders, and other stakeholders to discuss the emerging evidence on these unprecedented actions related to COVID-19 that could inform and advance pandemic and seasonal influenza vaccine preparedness efforts and subsequent response.
Agenda:
Panel 1: Global Roles and Mechanisms during a Health Emergency
- Ciro Ugarte, Moderator | Director, Health Emergencies, PAHO
- Michael Kremer | University of Chicago
- Youngmee Jee | CEO, Institut Pasteur Korea; Special Representative for Health Diplomacy, Korea Foundation
- Michael Ryan | Executive Director, Emergencies Programme, WHO
- Amadou Sall | CEO, Institut Pasteur, Dakar; Chairman, Global Alert Outbreak and Response Network
Panel 2: One Health Governance Gaps and Opportunities
- Malik Peiris, Moderator | Chair of Virology, University of Hong Kong
- Richard Webby | Director, Collaborating Center for Studies on the Ecology of Influenza in Animals, WHO
- James Wood | Head of Department of Veterinary Medicine, University of Cambridge
- Wenqing Zhang | Head, Global Influenza Programme, WHO
Breakout sessions
Breakout 1: Data Sharing and Transparency
- Keiji Fukuda, Moderator | Director and Clinical Professor at The University of Hong Kong School of Public Health
- Celia Alpuche Aranda | Director, Infectious Disease Research Center, National Institute of Public Health, Mexico
- Gian Luca Burci | Adjunct Professor of International Law at the Graduate Institute of International and Development Studies, Geneva
- Kanta Subbarao | Director, WHO Collaborating Centre for Reference and Research on Influenza
- Joshua Sharfstein | Vice Dean for Public Health Practice and Community Engagement, Johns Hopkins Bloomberg School of Public Health
Breakout 2: Animal and Human Health Surveillance
- Peter Daszak, Moderator | President, Ecohealth Alliance
- Dennis Carroll | Chair, Global Virome Research Project
- James Wood | Head of Department of Veterinary Medicine, University of Cambridge
Breakout 3: Equity and Financing
- Ok Pannenborg, Moderator | Former Chief Health Scientist, World Bank
- Peter Sands | Executive Director, The Global Fund
- Mark Jit | London School of Hygiene and Tropical Medicine
- Rodrigo Salvado | Deputy Director, Development Policy and Finance, Bill and Melinda Gates Foundation
The workshop will feature invited presentations and discussions to:
- Highlight late-breaking developments in vaccine R&D or manufacturing that can inform future pandemic influenza planning.
- Explore current global coordination frameworks and opportunities for future pandemic planning, including funding mobilization, technology transfer, and surveillance and data sharing.
- Discuss lessons learned from COVID-19 vaccine rollout and delivery, as well as public health countermeasures sourcing, including inventory unpredictability and cascading effects of shortages of critical inputs and ancillary materials.
- Explore gaps in One Health governance, global surveillance, and risk assessment.
- Highlight equity challenges in the “last mile” of medical product delivery, and needs identified in order to improve future planning and deployment of products.
- Explore innovations in surveillance and data sharing during COVID-19 and other epidemics that can be adapted and scaled for future influenza events.
- Discuss best practices for communicating emerging research and building public confidence in vaccines and public health measures.
The deliberations of this workshop will also inform the four study committees related to this project: (1) Vaccine research and development, including platforms in discovery and manufacturing, (2) Vaccine distribution and supply chain, (3) Non-vaccine public health interventions and countermeasures, and (4) International coordination, innovative partnerships, and sustainable financing for influenza preparedness and response.
